Metraipolis › archive › dc_b2ba71a85641

Pharmacogenomics of Rivaroxaban: Association of CYP3A4, CYP3A5, CYP2J2, ABCB1, and ABCG2 Variants with Bleeding and Thrombotic Outcomes in Real-World Clinical… — Europe PMC PMID:42514961

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42514961
DOI
10.3390/pharmaceutics18070884
License (as archived)
solo-consultazione
Archived
2026-10-18T03:45:39.321Z
SHA-256 of the archived text
5ca5ed89b662165723d09493f1c6e2a24a46dd67a33cb43f930e3566c265bbeb
Stable URL of this page
https://metraipolis.com/documento/dc_b2ba71a85641

How to cite

Pharmacogenomics of Rivaroxaban: Association of CYP3A4, CYP3A5, CYP2J2, ABCB1, and ABCG2 Variants with Bleeding and Thrombotic Outcomes in Real-World Clinical… — Europe PMC PMID:42514961 — Europe PMC (en), https://europepmc.org/article/MED/42514961 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_b2ba71a85641 (Metraipolis archive dc_b2ba71a85641, sha256 5ca5ed89b662165723d09493f1c6e2a24a46dd67a33cb43f930e3566c265bbeb)
BibTeX
@misc{dcb2ba71a85641,
  title = {Pharmacogenomics of Rivaroxaban: Association of CYP3A4, CYP3A5, CYP2J2, ABCB1, and ABCG2 Variants with Bleeding and Thrombotic Outcomes in Real-World Clinical… — Europe PMC PMID:42514961},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42514961},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_b2ba71a85641; sha256 5ca5ed89b662165723d09493f1c6e2a24a46dd67a33cb43f930e3566c265bbeb},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42514961. Agents can read the archived copy with the MCP tool read_document.